EE353 An Analysis of Stakeholders’ Contribution to High-WAC and Low-WAC Adalimumab Products in 2025 Under the Inflation Reduction Act in the United States
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.651
https://www.valueinhealthjournal.com/article/S1098-3015(24)00766-6/fulltext
Section Title :
Section Order :
10126
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00766-6&doi=10.1016/j.jval.2024.03.651